ArticleACS omega2026
IRACEMA: A Database Management System for Bioactive Compounds Obtained and Characterized by Brazilian Researchers.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioactive compounds are natural or synthetic substances with regulatory roles in metabolic processes. Brazil, known for its rich biodiversity and strong expertise in organic chemistry, holds great potential for discovering bioactive molecules. However, the vast amount of data generated in this field is often scattered and difficult to access. The IRACEMA (Innovative Research, Analysis, and Computational Exploration of Molecules Assembled in Brazil) project addresses this challenge by establishing the first comprehensive database of synthetic bioactive compounds in Brazil. This platform integrates biological activity data, manually curated from the literature, with cheminformatics-based predictions of physicochemical and ADME properties to facilitate the exploration of structure-activity relationships (SARs) by end users. The project's technical architecture employs modern web technologies for both frontend (React) and backend (NestJS/Node.js and Python/Flask microservices) development. The system delivers an interactive platform for molecular visualization and analysis, with PostgreSQL and Prisma ensuring robust data management. By democratizing access to data, IRACEMA (available at https://iracema.fcf.usp.br/) strengthens Brazil's position in bioactive compound research, bridging the gap between academic discoveries and real-world applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.